Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tabraiz A, Mohammed"'
Autor:
Glenn Liu, George Wilding, Dona Alberti, Jill M. Kolesar, Anne M. Traynor, Tabraiz A. Mohammed, Michael D. Keppen, Naoko Takebe, Jens C. Eickhoff, Rebecca Marnocha, William R. Schelman
Publikováno v:
Investigational New Drugs. 32:295-302
Background. A phase I, dose-escalation study of AT-101 with cisplatin and etoposide was conducted to determine the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D), safety and pharmacokinetics in patients with advanced solid tumors, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731395ccf14b9b105690b3e1543ed3b7
https://doi.org/10.1007/s10637-013-9999-7
https://doi.org/10.1007/s10637-013-9999-7
Autor:
Herbert Chen, Sam J. Lubner, Kyle D. Holen, Daniel Mulkerin, Noelle K. LoConte, William R. Schelman, Jens C. Eickhoff, Renata Jaskula-Sztul, Tabraiz A. Mohammed
Introduction. Notch1 has been shown to be a tumor suppressor in neuroendocrine tumors (NETs). Previous in vitro studies in NET cell lines have also suggested that valproic acid (VPA), a histone deacetylase inhibitor, can induce Notch1 and that Notch1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e91a456c59f8894b16ee1aa78a17e8d
https://europepmc.org/articles/PMC3121900/
https://europepmc.org/articles/PMC3121900/
Publikováno v:
Molecular Vision
Purpose: To localize specific components of the Basal Membrane Complex (BMC) of elongating lens fibers at defined points in their migration to the posterior sutures. Methods: Normal, juvenile (4-6 week old) Sprague-Dawley rat lenses (n=46) were utili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f8e9e559f4dea461306ffff0cfeae3f
https://pubmed.ncbi.nlm.nih.gov/18596883
https://pubmed.ncbi.nlm.nih.gov/18596883
Autor:
Jessica Schmacher, Maureen A. Smith, Heather B. Neuman, Tabraiz A. Mohammed, Emily R. Winslow, Noelle K. LoConte, Glenn O. Allen
Publikováno v:
Journal of Clinical Oncology. 32:338-338
338 Background: Retrospective data suggest that neoadjuvant therapy in patients with resectable pancreatic cancer may improve the R0 resection rate and potentially survival. We examined the impact of neoadjuvant therapy on survival rates at a populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3919453713e6870c7b3236496be04b88
https://doi.org/10.1200/jco.2014.32.3_suppl.338
https://doi.org/10.1200/jco.2014.32.3_suppl.338